These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 19047819)
21. Empiric carbapenem monotherapy in pediatric bone marrow transplant recipients. Nelson WK; Rayback PA; Quinones R; Giller RH Ann Pharmacother; 2002 Sep; 36(9):1360-5. PubMed ID: 12196052 [TBL] [Abstract][Full Text] [Related]
22. Meropenem versus imipenem/cilastatin in the treatment of sepsis in Chinese patients. Kuo BI; Fung CP; Liu CY Zhonghua Yi Xue Za Zhi (Taipei); 2000 May; 63(5):361-7. PubMed ID: 10862445 [TBL] [Abstract][Full Text] [Related]
23. Safe use of meropenem in a patient with a possible nonimmediate allergy to imipenem. Lakhal K; Lortat-Jacob B; Neukirch C; Pajot O; Wolff M Pharmacotherapy; 2007 Sep; 27(9):1334-8. PubMed ID: 17723087 [TBL] [Abstract][Full Text] [Related]
24. Drug utilization evaluation of imipenem/cilastatin in patients with renal dysfunction. Sheakely ML; Nicolau DP; Agner SI Ann Pharmacother; 1993; 27(7-8):981-2. PubMed ID: 8364293 [No Abstract] [Full Text] [Related]
25. The pharmacology of meropenem, a new carbapenem antibiotic. Craig WA Clin Infect Dis; 1997 Feb; 24 Suppl 2():S266-75. PubMed ID: 9126702 [TBL] [Abstract][Full Text] [Related]
26. Meropenem versus imipenem/cilastatin in the treatment of intra-abdominal infections. Brismar B; Malmborg AS; Tunevall G; Lindgren V; Bergman L; Mentzing LO; Nyström PO; Anséhn S; Bäckstrand B; Skau T J Antimicrob Chemother; 1995 Jan; 35(1):139-48. PubMed ID: 7768761 [TBL] [Abstract][Full Text] [Related]
27. Multicenter randomized trial comparing meropenem (1.5 g daily) and imipenem/cilastatin (2 g daily) in the hospital treatment of community-acquired pneumonia. Bartoloni A; Strohmeyer M; Corti G; Buonomini MI; Franchino L; Romanelli G; Moretti AM; De Vizzi GB; Petraglia A; Mancini P; Atzeni R; Fogliani V; Giura R; Paradisi F Drugs Exp Clin Res; 1999; 25(6):243-52. PubMed ID: 10713862 [TBL] [Abstract][Full Text] [Related]
28. Retrospective evaluation of piperacillin-tazobactam, imipenem-cilastatin and meropenem used on surgical floors at a tertiary care hospital in Saudi Arabia. Youssif E; Aseeri M; Khoshhal S J Infect Public Health; 2018; 11(4):486-490. PubMed ID: 29153444 [TBL] [Abstract][Full Text] [Related]
29. Efficacy of doripenem in the treatment of Pseudomonas aeruginosa experimental pneumonia versus imipenem and meropenem. Bretonnière C; Jacqueline C; Caillon J; Guitton C; Le Mabecque V; Miégeville AF; Villers D; Potel G; Boutoille D J Antimicrob Chemother; 2010 Nov; 65(11):2423-7. PubMed ID: 20858688 [TBL] [Abstract][Full Text] [Related]
30. A Retrospective Study on the Incidence of Seizures among Neurosurgical Patients Who Treated with Imipenem/Cilastatin or Meropenem. Wu Y; Chen K; Shi Z; Wang Q Curr Pharm Biotechnol; 2014; 15(8):685-90. PubMed ID: 25051950 [TBL] [Abstract][Full Text] [Related]
31. [Investigation on administration method of carbapenems]. Mikamo H; Ninomiya M; Tamaya T Jpn J Antibiot; 2002 Dec; 55(6):875-81. PubMed ID: 12621741 [TBL] [Abstract][Full Text] [Related]
32. A multicenter comparative study of meropenem and imipenem/cilastatin in the treatment of complicated urinary tract infections in hospitalized patients. Cox CE; Holloway WJ; Geckler RW Clin Infect Dis; 1995 Jul; 21(1):86-92. PubMed ID: 7578765 [TBL] [Abstract][Full Text] [Related]
33. Stability of meropenem and doripenem solutions for administration by continuous infusion. Berthoin K; Le Duff CS; Marchand-Brynaert J; Carryn S; Tulkens PM J Antimicrob Chemother; 2010 May; 65(5):1073-5. PubMed ID: 20176578 [No Abstract] [Full Text] [Related]